Tag: 4D Pharma PLC
4D Shares to Retain Listing on AIM After Merged Company Shares Listing on NASDAQ
A Leeds-based pharmaceutical company specializing in the development of live biotherapeutics has entered into a merger agreement with a US company with the company expected to become listed on NASDAQ
Shares of 4D Pharma PLC (LON: DDDD) today fell 284% despite the announcement of the first positive results of the phase II trial of Blautix®